| 1 |
The genomic complexity of primary human prostate cancer
Michael F. Berger et al. · Nature
Open access |
Feb 2011 |
1,267 |
| 2 |
The Lancet Commission on prostate cancer: planning for the surge in cases
Nicholas David James et al. · The Lancet
Open access |
Apr 2024 |
723 |
| 3 |
Management of Patients with Advanced Prostate Cancer: The Report of the Advanced Prostate Cancer Consensus Conference APCCC 2017
Silke Gillessen et al. · European Urology
Open access |
24 Jun 2017 |
644 |
| 4 |
Tracking the clonal origin of lethal prostate cancer
Michael C. Haffner, Timothy L. Mosbruger, David Esopi et al. · Journal of Clinical Investigation
Open access |
25 Oct 2013 |
513 |
| 5 |
Multi-institutional analysis of long-term outcome for stages T1–T2 prostate cancer treated with permanent seed implantation
Michael J. Zeléfsky, Deborah Ann Kuban, Larry B. Levy et al. · International Journal of Radiation Oncology*Biology*Physics
|
3 Nov 2006 |
468 |
| 6 |
Comparative analysis of prostate‐specific antigen free survival outcomes for patients with low, intermediate and high risk prostate cancer treatment by radical therapy. Results from the Prostate Cancer Results Study Group
Peter Grimm et al. · British Journal of Urology
|
12 Jan 2012 |
461 |
| 7 |
American Brachytherapy Society consensus guidelines for transrectal ultrasound-guided permanent prostate brachytherapy
Brian J. Davis, Eric Mark Horwitz, W. Robert Lee et al. · Brachytherapy
|
2012 |
457 |
| 8 |
Aggressive Variants of Castration-Resistant Prostate Cancer
Himisha Beltran, Scott Arthur Tomlins, Ana Maria Aparicio et al. · Clinical Cancer Research
Open access |
12 Apr 2014 |
436 |
| 9 |
Management of Patients with Advanced Prostate Cancer: Report of the Advanced Prostate Cancer Consensus Conference 2019
Silke Gillessen et al. · European Urology
Open access |
27 Jan 2020 |
400 |
| 10 |
Association Between Choice of Radical Prostatectomy, External Beam Radiotherapy, Brachytherapy, or Active Surveillance and Patient-Reported Quality of Life Among Men With Localized Prostate Cancer
Ronald C. Chen, Ramsankar Basak, Anne-Marie Meyer et al. · JAMA
Open access |
21 Mar 2017 |
332 |
| 11 |
Free, Complexed and Total Serum Prostate Specific Antigen: The Establishment of Appropriate Reference Ranges for their Concentrations and Ratios
Joseph E. Oesterling, Steven J. Jacobsen, George G. Klee et al. · The Journal of Urology
|
Sep 1995 |
327 |
| 12 |
Management of patients with advanced prostate cancer: recommendations of the St Gallen Advanced Prostate Cancer Consensus Conference (APCCC) 2015
Silke Gillessen et al. · Annals of Oncology
Open access |
4 Jun 2015 |
324 |
| 13 |
Implementation of Germline Testing for Prostate Cancer: Philadelphia Prostate Cancer Consensus Conference 2019
Veda N. Giri et al. · Journal of Clinical Oncology
Open access |
9 Jun 2020 |
282 |
| 14 |
Anatomical grades of nerve sparing: a risk‐stratified approach to neural‐hammock sparing during robot‐assisted radical prostatectomy (RARP)
Ashutosh Kumar Tewari, Abhishek S. Srivastava, Michael W. Huang et al. · British Journal of Urology
|
Sep 2011 |
236 |
| 15 |
Nanotechnology for targeted cancer therapy
May Dongmei Wang, Dong Moon Shin, Jonathan W. Simons et al. · Expert Review of Anticancer Therapy
|
Jun 2007 |
217 |
| 16 |
TRAP-1, the mitochondrial Hsp90
Dario C. Altieri, Gary Stephen Stein, Jane B. Lian et al. · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
Open access |
22 Aug 2011 |
190 |
| 17 |
Cloning, expression, genomic localization, and enzymatic activities of the mouse homolog of prostate-specific membrane antigen/NAALADase/folate hydrolase
Dean J. Bacich, John Thomas Pinto, William P. Tong et al. · Mammalian Genome
|
Feb 2001 |
177 |
| 18 |
Management of patients with advanced prostate cancer—metastatic and/or castration-resistant prostate cancer: Report of the Advanced Prostate Cancer Consensus Conference (APCCC) 2022
Silke Gillessen et al. · European Journal of Cancer
Open access118 authors |
2 Mar 2023 |
166 |
| 19 |
Fifteen-Year Biochemical Relapse-Free Survival, Cause-Specific Survival, and Overall Survival Following I125 Prostate Brachytherapy in Clinically Localized Prostate Cancer: Seattle Experience
John E. Sylvester, Peter Grimm, J K Wong et al. · International Journal of Radiation Oncology*Biology*Physics
|
24 Sep 2010 |
166 |
| 20 |
Exploiting the mitochondrial unfolded protein response for cancer therapy in mice and human cells
Markus David Siegelin, Takehiko Dohi, Christopher M. Raskett et al. · Journal of Clinical Investigation
Open access |
Mar 2011 |
160 |
| 21 |
Signaling and stress: The redox landscape in NOS2 biology
Douglas D. Thomas, Julie L. Heinecke, Lisa A. Ridnour et al. · Free Radical Biology and Medicine
Open access |
24 Jun 2015 |
153 |
| 22 |
Reproducibility: changing the policies and culture of cell line authentication
Leonard P. Freedman, Mark C. Gibson, Stephen P. Ethier et al. · Nature Methods
|
28 May 2015 |
146 |
| 23 |
Prediction of overall survival for patients with metastatic castration-resistant prostate cancer: development of a prognostic model through a crowdsourced challenge with open clinical trial data
Justin Guinney et al. · The Lancet Oncology
Open access196 authors |
16 Nov 2016 |
144 |
| 24 |
The current state of preclinical prostate cancer animal models
Kenneth J. Pienta, Cory T. Abate-Shen, David B. Agus et al. · The Prostate
Open access |
22 Jan 2008 |
135 |
| 25 |
Management of Patients with Advanced Prostate Cancer. Report from the 2024 Advanced Prostate Cancer Consensus Conference (APCCC)
Silke Gillessen et al. · European Urology
Open access121 authors |
11 Oct 2024 |
133 |
| 26 |
Role of Androgen Receptor Variants in Prostate Cancer: Report from the 2017 Mission Androgen Receptor Variants Meeting
Jun Hui Luo et al. · European Urology
Open access |
16 Dec 2017 |
132 |
| 27 |
Management of Patients with Advanced Prostate Cancer: Report from the Advanced Prostate Cancer Consensus Conference 2021
Silke Gillessen et al. · European Urology
Open access |
18 Apr 2022 |
131 |
| 28 |
Novel therapies are changing treatment paradigms in metastatic prostate cancer
Eric R. Powers, Georgia Sofia Karachaliou, Chester Kao et al. · Journal of Hematology & Oncology
Open access |
28 Oct 2020 |
124 |
| 29 |
Management of Patients with Advanced Prostate Cancer. Part I: Intermediate-/High-risk and Locally Advanced Disease, Biochemical Relapse, and Side Effects of Hormonal Treatment: Report of the Advanced Prostate Cancer Consensus Conference 2022
Silke Gillessen et al. · European Urology
Open access118 authors |
6 Dec 2022 |
123 |
| 30 |
Time‐dependent effects of hormone‐deprivation therapy on prostate metabolism as detected by combined magnetic resonance imaging and 3D magnetic resonance spectroscopic imaging
Ullrich G. Müeller-Lisse, Mark G. Swanson, Daniel B. Vigneron et al. · Magnetic Resonance in Medicine
Open access |
Jul 2001 |
121 |
| 31 |
Interobserver variability leads to significant differences in quantifiers of prostate implant adequacy
W. Robert Lee, Mack Roach, Jeff M. Michalski et al. · International Journal of Radiation Oncology*Biology*Physics
Open access |
Oct 2002 |
115 |
| 32 |
Report of a consensus meeting on focal low dose rate brachytherapy for prostate cancer
Stephen E M Langley, Hashim Uddin Ahmed, Bashar M. Al‐Qaisieh et al. · British Journal of Urology
|
12 Jan 2012 |
112 |
| 33 |
Initial Management of Noncastrate Advanced, Recurrent, or Metastatic Prostate Cancer: ASCO Guideline Update
Katherine S. Virgo, R. Bryan Rumble, Ronald de Wit et al. · Journal of Clinical Oncology
Open access |
26 Jan 2021 |
108 |
| 34 |
Fifteen-Year Survival Outcomes Following Primary Androgen-Deprivation Therapy for Localized Prostate Cancer
Grace L. Lu‐Yao, Peter C. Albertsen, Dirk F. Moore et al. · JAMA Internal Medicine
Open access |
14 Jul 2014 |
102 |
| 35 |
Prostate Cancer Racial Disparities: A Systematic Review by the Prostate Cancer Foundation Panel
Brandon Arvin Virgil Mahal, Travis A. Gerke, Shivanshu Awasthi et al. · European Urology Oncology
ReviewOpen access |
24 Aug 2021 |
100 |
| 36 |
Raman Molecular Imaging: A Novel Spectroscopic Technique for Diagnosis of Bladder Cancer in Urine Specimens
Amos Shapiro, Ofer Nathan Gofrit, Galina Pizov et al. · European Urology
|
23 Oct 2010 |
95 |
| 37 |
Complications, Recovery, and Early Functional Outcomes and Oncologic Control Following In-bore Focal Laser Ablation of Prostate Cancer
Herbert Lepor, Elton Llukani, D Sperling et al. · European Urology
|
6 Jun 2015 |
94 |
| 38 |
Impact of the Cell Cycle Progression Test on Physician and Patient Treatment Selection for Localized Prostate Cancer
Neal D. Shore, Naveen Kella, Brian Joseph Moran et al. · The Journal of Urology
|
25 Sep 2015 |
82 |
| 39 |
Re-biopsy of the Prostate Using a Stereotactic Transperineal Technique
Brian Joseph Moran, Michelle H. Braccioforte, Dean J. Conterato · The Journal of Urology
|
4 Sep 2006 |
81 |
| 40 |
Phase II Evaluations of Cilengitide in Asymptomatic Patients with Androgen-Independent Prostate Cancer: Scientific Rationale and Study Design
Kathleen W. Beekman, Alexander Dimitrios Colevas, Kathleen A. Cooney et al. · Clinical Genitourinary Cancer
|
Mar 2006 |
81 |
| 41 |
Concordance of DNA Repair Gene Mutations in Paired Primary Prostate Cancer Samples and Metastatic Tissue or Cell-Free DNA
Michael Thomas Schweizer, Smruthy Sivakumar, Hanna Tukachinsky et al. · JAMA Oncology
Open access |
4 Jun 2021 |
79 |
| 42 |
Surgery vs Radiotherapy in the Management of Biopsy Gleason Score 9-10 Prostate Cancer and the Risk of Mortality
Derya Tilki, Ming‐Hui Chen, Jing Wu et al. · JAMA Oncology
Open access |
19 Nov 2018 |
79 |
| 43 |
Association of androgen‐deprivation therapy with excess cardiac‐specific mortality in men with prostate cancer
David R. Ziehr, Ming‐Hui Chen, Danjie Zhang et al. · British Journal of Urology
|
15 Aug 2014 |
79 |
| 44 |
Accelerating precision medicine in metastatic prostate cancer
Joaquı́n Mateo et al. · Nature Cancer
Open access |
17 Nov 2020 |
78 |
| 45 |
Late Gastrointestinal Toxicities Following Radiation Therapy for Prostate Cancer
Sung Hoon Kim, Shunhua Shen, Dirk F. Moore et al. · European Urology
Open access |
20 Jun 2011 |
78 |
| 46 |
Alfuzosin for treatment of lower urinary tract symptoms compatible with benign prostatic hyperplasia: A systematic review of efficacy and adverse effects
Roderick H. MacDonald, Timothy J Wilt · Urology
Review |
Oct 2005 |
75 |
| 47 |
Impact of a clinical pathway for radical retropubic prostatectomy
BryanD Leibman, Özdal Dillioğlugil, Farhat Abbas et al. · Urology
|
Jul 1998 |
74 |
| 48 |
Risk Group and Death From Prostate Cancer
Ann Caroline Raldow, Danjie Zhang, Ming‐Hui Chen et al. · JAMA Oncology
|
19 Feb 2015 |
74 |
| 49 |
Influence of Androgen Deprivation Therapy on All-Cause Mortality in Men With High-Risk Prostate Cancer and a History of Congestive Heart Failure or Myocardial Infarction
Paul Linh Nguyen, Ming‐Hui Chen, Joshua A. Beckman et al. · International Journal of Radiation Oncology*Biology*Physics
|
29 Jun 2011 |
74 |
| 50 |
Multiphoton microscopy for structure identification in human prostate and periprostatic tissue: implications in prostate cancer surgery
Ashutosh Kumar Tewari, Maria M. Shevchuk, Joshua Sterling et al. · British Journal of Urology
Open access |
28 Mar 2011 |
70 |